ENTX
ENTX
NASDAQ · Biotechnology

Entera Bio Ltd

$1.77
+0.12 (+7.27%)
As of Jun 30, 10:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
45.2K
Net Income
-12,428,880
Gross Margin
Profit Margin
-27,235.7%
Rev Growth
-31.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.1% 38.1%
Operating Margin -27,450.0% -24,705.2% -24.8% -21.3%
Profit Margin -27,235.7% -25,873.9% -30.8% -22.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 45.2K 65.8K 9.20M 8.70M
Gross Profit 3.50M 3.31M
Operating Income -12,401,086 -16,264,904 -2,286,472 -1,856,846
Net Income -12,428,880 -16,301,358 -2,830,498 -1,987,756
Gross Margin 38.1% 38.1%
Operating Margin -27,450.0% -24,705.2% -24.8% -21.3%
Profit Margin -27,235.7% -25,873.9% -30.8% -22.8%
Rev Growth -31.4% -31.4% +9.2% +11.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 7.94M 8.67M
Total Equity 25.38M 23.96M
D/E Ratio 0.31 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -12,494,137 -17,297,333 -2,581,372 -2,786,589
Free Cash Flow -3,568,526 -2,022,520